Cover Image
Market Research Report
Product code 
1090861

Implantable Medical Devices Market By Product (Orthopedic Implants, Cardiovascular Implants , Intraocular Lens , Dental Implants, Breast Implants, Other Implants), : Global Opportunity Analysis and Industry Forecast, 2020-2030

Published: | Allied Market Research | 225 Pages | Delivery time: 2-3 business days

Price

Back to Top
Implantable Medical Devices Market By Product (Orthopedic Implants, Cardiovascular Implants , Intraocular Lens , Dental Implants, Breast Implants, Other Implants), : Global Opportunity Analysis and Industry Forecast, 2020-2030
Published: March 1, 2022
Allied Market Research
Content info: 225 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global implantable medical devices market was valued at $91,868.94 million in 2020, and is projected to reach $179,032.75 million by 2030, registering a CAGR of 7.2% from 2021 to 2030. Implantable medical devices are surgically transplanted inside the body. These implants are used to replace or support any damaged body organ to enhance function of any body organ or to detect errors in normal body functioning. These devices can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. These implantable devices are made up of bone, tissue, skin, ceramics, metals, and other natural materials.

The rise in prevalence of chronic diseases coupled with the rapidly ageing population drives the growth of the market. Moreover, increased awareness and technological advancements in medical implants also contributes toward the growth of the market. However, high implantation cost and lack of trained professionals in the medical surgeries sector are the major barriers for the growth of the market. Conversely, the surge in number of the reimbursement policies is expected to offer lucrative opportunities for market expansion during the forecast period. 

The implantable medical devices market is segmented on the basis of product and region. By product, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses and other implants. The orthopedic implants are further classified as spinal implants and reconstructive joint replacements. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the implantable medical devices market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Market Segments

By BY PRODUCT

  • Breast Implants
  • Other Implants
  • Orthopedic Implants
  • Cardiovascular Implants
  • Intraocular Lens
  • Dental Implants

By BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • Biotronik SE and Co. KG
    • Boston Scientific Corporation
    • C. R. Bard, Inc.
    • Cardinal Health, Inc.
    • CONMED Corporation
    • Globus Medical, Inc.
    • Integra LifeSciences Holdings Corporation
    • Johnson and Johnson
    • LivaNova PLC
Product Code: A00392

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Orthopedic Implants
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Cardiovascular Implants 
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Intraocular Lens 
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Dental Implants
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Breast Implants
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Other Implants
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 North America
    • 5.2.1 Key trends and opportunities
    • 5.2.2 North America Market size and forecast, by Product
    • 5.2.3 North America Market size and forecast, by country
      • 5.2.3.1 U.S.
      • 5.2.3.1.1 Market size and forecast, by Product
      • 5.2.3.2 Canada
      • 5.2.3.2.1 Market size and forecast, by Product
      • 5.2.3.3 Mexico
      • 5.2.3.3.1 Market size and forecast, by Product
  • 5.3 Europe
    • 5.3.1 Key trends and opportunities
    • 5.3.2 Europe Market size and forecast, by Product
    • 5.3.3 Europe Market size and forecast, by country
      • 5.3.3.1 Germany
      • 5.3.3.1.1 Market size and forecast, by Product
      • 5.3.3.2 France
      • 5.3.3.2.1 Market size and forecast, by Product
      • 5.3.3.3 United Kingdom
      • 5.3.3.3.1 Market size and forecast, by Product
      • 5.3.3.4 Italy
      • 5.3.3.4.1 Market size and forecast, by Product
      • 5.3.3.5 Spain
      • 5.3.3.5.1 Market size and forecast, by Product
      • 5.3.3.6 Rest of Europe
      • 5.3.3.6.1 Market size and forecast, by Product
  • 5.4 Asia-Pacific
    • 5.4.1 Key trends and opportunities
    • 5.4.2 Asia-Pacific Market size and forecast, by Product
    • 5.4.3 Asia-Pacific Market size and forecast, by country
      • 5.4.3.1 Japan
      • 5.4.3.1.1 Market size and forecast, by Product
      • 5.4.3.2 China
      • 5.4.3.2.1 Market size and forecast, by Product
      • 5.4.3.3 Australia
      • 5.4.3.3.1 Market size and forecast, by Product
      • 5.4.3.4 India
      • 5.4.3.4.1 Market size and forecast, by Product
      • 5.4.3.5 South Korea
      • 5.4.3.5.1 Market size and forecast, by Product
      • 5.4.3.6 Rest of Asia-Pacific
      • 5.4.3.6.1 Market size and forecast, by Product
  • 5.5 LAMEA
    • 5.5.1 Key trends and opportunities
    • 5.5.2 LAMEA Market size and forecast, by Product
    • 5.5.3 LAMEA Market size and forecast, by country
      • 5.5.3.1 Brazil
      • 5.5.3.1.1 Market size and forecast, by Product
      • 5.5.3.2 Saudi Arabia
      • 5.5.3.2.1 Market size and forecast, by Product
      • 5.5.3.3 South Africa
      • 5.5.3.3.1 Market size and forecast, by Product
      • 5.5.3.4 Rest of LAMEA
      • 5.5.3.4.1 Market size and forecast, by Product

CHAPTER 6: COMPANY LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product Mapping of Top 10 Player
  • 6.4. Competitive Dashboard
  • 6.5. Competitive Heatmap
  • 6.6. Key developments

CHAPTER 7: COMPANY PROFILES

  • 7.1 Abbott Laboratories
    • 7.1.1 Company overview
    • 7.1.2 Company snapshot
    • 7.1.3 Operating business segments
    • 7.1.4 Product portfolio
    • 7.1.5 Business performance
    • 7.1.6 Key strategic moves and developments
  • 7.2 Biotronik SE and Co. KG
    • 7.2.1 Company overview
    • 7.2.2 Company snapshot
    • 7.2.3 Operating business segments
    • 7.2.4 Product portfolio
    • 7.2.5 Business performance
    • 7.2.6 Key strategic moves and developments
  • 7.3 Boston Scientific Corporation
    • 7.3.1 Company overview
    • 7.3.2 Company snapshot
    • 7.3.3 Operating business segments
    • 7.3.4 Product portfolio
    • 7.3.5 Business performance
    • 7.3.6 Key strategic moves and developments
  • 7.4 C. R. Bard, Inc.
    • 7.4.1 Company overview
    • 7.4.2 Company snapshot
    • 7.4.3 Operating business segments
    • 7.4.4 Product portfolio
    • 7.4.5 Business performance
    • 7.4.6 Key strategic moves and developments
  • 7.5 Cardinal Health, Inc.
    • 7.5.1 Company overview
    • 7.5.2 Company snapshot
    • 7.5.3 Operating business segments
    • 7.5.4 Product portfolio
    • 7.5.5 Business performance
    • 7.5.6 Key strategic moves and developments
  • 7.6 CONMED Corporation
    • 7.6.1 Company overview
    • 7.6.2 Company snapshot
    • 7.6.3 Operating business segments
    • 7.6.4 Product portfolio
    • 7.6.5 Business performance
    • 7.6.6 Key strategic moves and developments
  • 7.7 Globus Medical, Inc.
    • 7.7.1 Company overview
    • 7.7.2 Company snapshot
    • 7.7.3 Operating business segments
    • 7.7.4 Product portfolio
    • 7.7.5 Business performance
    • 7.7.6 Key strategic moves and developments
  • 7.8 Integra LifeSciences Holdings Corporation
    • 7.8.1 Company overview
    • 7.8.2 Company snapshot
    • 7.8.3 Operating business segments
    • 7.8.4 Product portfolio
    • 7.8.5 Business performance
    • 7.8.6 Key strategic moves and developments
  • 7.9 Johnson and Johnson
    • 7.9.1 Company overview
    • 7.9.2 Company snapshot
    • 7.9.3 Operating business segments
    • 7.9.4 Product portfolio
    • 7.9.5 Business performance
    • 7.9.6 Key strategic moves and developments
  • 7.10 LivaNova PLC
    • 7.10.1 Company overview
    • 7.10.2 Company snapshot
    • 7.10.3 Operating business segments
    • 7.10.4 Product portfolio
    • 7.10.5 Business performance
    • 7.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
  • TABLE 2. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR ORTHOPEDIC IMPLANTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 3. IMPLANTABLE MEDICAL DEVICES MARKET ORTHOPEDIC IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 4. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR CARDIOVASCULAR IMPLANTS , BY REGION , 2020-2030,($MILLION)
  • TABLE 5. IMPLANTABLE MEDICAL DEVICES MARKET CARDIOVASCULAR IMPLANTS  BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 6. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR INTRAOCULAR LENS , BY REGION , 2020-2030,($MILLION)
  • TABLE 7. IMPLANTABLE MEDICAL DEVICES MARKET INTRAOCULAR LENS  BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 8. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR DENTAL IMPLANTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 9. IMPLANTABLE MEDICAL DEVICES MARKET DENTAL IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 10. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR BREAST IMPLANTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 11. IMPLANTABLE MEDICAL DEVICES MARKET BREAST IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 12. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR OTHER IMPLANTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 13. IMPLANTABLE MEDICAL DEVICES MARKET OTHER IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 14. IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
  • TABLE 15. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
  • TABLE 16. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 17. U.S. IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 18. CANADA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 19. MEXICO IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 20. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
  • TABLE 21. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 22. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 23. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 24. UNITED KINGDOM IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 25. ITALY IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 26. SPAIN IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 27. REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 28. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
  • TABLE 29. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 30. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 31. CHINA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 32. AUSTRALIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 33. INDIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 34. SOUTH KOREA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 35. REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 36. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
  • TABLE 37. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 38. BRAZIL IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 39. SAUDI ARABIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 40. SOUTH AFRICA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 41. REST OF LAMEA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
  • TABLE 42.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 43.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 44.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 45.ABBOTT LABORATORIES: NET SALES,
  • TABLE 46.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 47.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
  • TABLE 48.BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
  • TABLE 49.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 50.BIOTRONIK SE AND CO. KG: NET SALES,
  • TABLE 51.BIOTRONIK SE AND CO. KG: KEY STRATERGIES
  • TABLE 52.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 53.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 54.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 55.BOSTON SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 56.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 57.C. R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 58.C. R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 59.C. R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 60.C. R. BARD, INC.: NET SALES,
  • TABLE 61.C. R. BARD, INC.: KEY STRATERGIES
  • TABLE 62.CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 63.CARDINAL HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 64.CARDINAL HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 65.CARDINAL HEALTH, INC.: NET SALES,
  • TABLE 66.CARDINAL HEALTH, INC.: KEY STRATERGIES
  • TABLE 67.CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 68.CONMED CORPORATION: OPERATING SEGMENTS
  • TABLE 69.CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 70.CONMED CORPORATION: NET SALES,
  • TABLE 71.CONMED CORPORATION: KEY STRATERGIES
  • TABLE 72.GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 73.GLOBUS MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 74.GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 75.GLOBUS MEDICAL, INC.: NET SALES,
  • TABLE 76.GLOBUS MEDICAL, INC.: KEY STRATERGIES
  • TABLE 77.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 78.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 79.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 80.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES,
  • TABLE 81.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATERGIES
  • TABLE 82.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 83.JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 84.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 85.JOHNSON AND JOHNSON: NET SALES,
  • TABLE 86.JOHNSON AND JOHNSON: KEY STRATERGIES
  • TABLE 87.LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 88.LIVANOVA PLC: OPERATING SEGMENTS
  • TABLE 89.LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 90.LIVANOVA PLC: NET SALES,
  • TABLE 91.LIVANOVA PLC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION
  • FIGURE 2.IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030
  • FIGURE 3.IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.IMPLANTABLE MEDICAL DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11.IMPLANTABLE MEDICAL DEVICES MARKET,BY PRODUCT,2020(%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR IMPLANTS  IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTRAOCULAR LENS  IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DENTAL IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BREAST IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHER IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
  • FIGURE 18.IMPLANTABLE MEDICAL DEVICES MARKET BY REGION,2020
  • FIGURE 19.U.S. IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 20.CANADA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 21.MEXICO IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 22.GERMANY IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 23.FRANCE IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 24.UNITED KINGDOM IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 25.ITALY IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 26.SPAIN IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 27.REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 28.JAPAN IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 29.CHINA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 30.AUSTRALIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 31.INDIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 32.SOUTH KOREA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 33.REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 34.BRAZIL IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 35.SAUDI ARABIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 36.SOUTH AFRICA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 37.REST OF LAMEA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
  • FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 42.COMPETITIVE DASHBOARD
  • FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 45.BIOTRONIK SE AND CO. KG.: NET SALES ,($MILLION)
  • FIGURE 46.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 47.C. R. BARD, INC..: NET SALES ,($MILLION)
  • FIGURE 48.CARDINAL HEALTH, INC..: NET SALES ,($MILLION)
  • FIGURE 49.CONMED CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 50.GLOBUS MEDICAL, INC..: NET SALES ,($MILLION)
  • FIGURE 51.INTEGRA LIFESCIENCES HOLDINGS CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 52.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
  • FIGURE 53.LIVANOVA PLC.: NET SALES ,($MILLION)